Ovarian fibroma

Jump to navigation Jump to search
Ovarian fibroma
MRI: Ovarian fibroma.
Image courtesy of RadsWiki

WikiDoc Resources for Ovarian fibroma

Articles

Most recent articles on Ovarian fibroma

Most cited articles on Ovarian fibroma

Review articles on Ovarian fibroma

Articles on Ovarian fibroma in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Ovarian fibroma

Images of Ovarian fibroma

Photos of Ovarian fibroma

Podcasts & MP3s on Ovarian fibroma

Videos on Ovarian fibroma

Evidence Based Medicine

Cochrane Collaboration on Ovarian fibroma

Bandolier on Ovarian fibroma

TRIP on Ovarian fibroma

Clinical Trials

Ongoing Trials on Ovarian fibroma at Clinical Trials.gov

Trial results on Ovarian fibroma

Clinical Trials on Ovarian fibroma at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Ovarian fibroma

NICE Guidance on Ovarian fibroma

NHS PRODIGY Guidance

FDA on Ovarian fibroma

CDC on Ovarian fibroma

Books

Books on Ovarian fibroma

News

Ovarian fibroma in the news

Be alerted to news on Ovarian fibroma

News trends on Ovarian fibroma

Commentary

Blogs on Ovarian fibroma

Definitions

Definitions of Ovarian fibroma

Patient Resources / Community

Patient resources on Ovarian fibroma

Discussion groups on Ovarian fibroma

Patient Handouts on Ovarian fibroma

Directions to Hospitals Treating Ovarian fibroma

Risk calculators and risk factors for Ovarian fibroma

Healthcare Provider Resources

Symptoms of Ovarian fibroma

Causes & Risk Factors for Ovarian fibroma

Diagnostic studies for Ovarian fibroma

Treatment of Ovarian fibroma

Continuing Medical Education (CME)

CME Programs on Ovarian fibroma

International

Ovarian fibroma en Espanol

Ovarian fibroma en Francais

Business

Ovarian fibroma in the Marketplace

Patents on Ovarian fibroma

Experimental / Informatics

List of terms related to Ovarian fibroma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Contributors: Cafer Zorkun M.D., PhD.


Overview

Ovarian fibromas account for approximately 4% of all ovarian neoplasms and are the most common sex cord tumor. Fibromas are generally asymptomatic and typically detected in middle-aged women at palpation during routine gynecologic examination. They are associated with ascites in 40% of cases and with pleural effusions in a small percentage of cases. Meig syndrome consists of an ovarian fibroma with ascites and a pleural effusion. [1] [2]

Epidemiology

Fibromas are seen in 75% of patients with nevoid basal cell carcinoma syndrome.

Diagnosis

Ultrasonography

Fibromas most commonly manifest as solid, hypoechoic masses with sound attenuation; however, the US appearance is variable.

Computed Tomography

Fibromas manifest as diffuse, slightly hypoattenuating masses with poor, very slow contrast enhancement.

Magnetic Resonance Imaging

Fibromas demonstrate homogeneous, relatively low signal intensity on T1-weighted MR images. On T2-weighted images, fibromas appear as well-circumscribed masses with low signal intensity containing scattered high-signal-intensity areas representing edema or cystic degeneration.

Diagnostic Findings

Ultrasonography

Images courtesy of RadsWiki

Magnetic Resonance Imaging

Images courtesy of RadsWiki

Pathology

References

  1. Ricardo B. Fonseca, and Ewa F. Grzeszczak. Case 128: Bilateral Ovarian Fibromas in Nevoid Basal Cell Carcinoma Syndrome. Radiology 2008 246: 318-321.
  2. Yong-Yeon Jeong, Eric K. Outwater, and Heoun Keun Kang. Imaging Evaluation of Ovarian Masses. RadioGraphics 2000 20: 1445-1470.

See Also

External Links


Template:WikiDoc Sources